Abstract
Daphniphyllum alkaloids are a growing group of secondary metabolites of great structural diversity, with complex polycyclic skeletons from Daphniphyllum plants. A large number of new Daphniphyllum alkaloids with novel frameworks have been isolated from Daphniphyllum species in the past decade. These unusual structural characteristics will attract the attention of scientists in the fields of organic synthesis, bioactivity evaluation and biosynthetic studies. This review lists all the Daphniphyllum alkaloids as well as their biosynthesis, bioactivity and synthesis reported by the end of first half of 2008.
Keywords: Daphniphyllum, alkaloids, secondary metabolites, polycyclic skeletons, organic synthesis, biosynthesis, bioactivity
Current Organic Chemistry
Title: The Daphniphyllum Alkaloids
Volume: 13 Issue: 6
Author(s): Mei Dong, Man-Li Zhang, Qing-Wen Shi, Yu-Cheng Gu and Hiromasa Kiyota
Affiliation:
Keywords: Daphniphyllum, alkaloids, secondary metabolites, polycyclic skeletons, organic synthesis, biosynthesis, bioactivity
Abstract: Daphniphyllum alkaloids are a growing group of secondary metabolites of great structural diversity, with complex polycyclic skeletons from Daphniphyllum plants. A large number of new Daphniphyllum alkaloids with novel frameworks have been isolated from Daphniphyllum species in the past decade. These unusual structural characteristics will attract the attention of scientists in the fields of organic synthesis, bioactivity evaluation and biosynthetic studies. This review lists all the Daphniphyllum alkaloids as well as their biosynthesis, bioactivity and synthesis reported by the end of first half of 2008.
Export Options
About this article
Cite this article as:
Dong Mei, Zhang Man-Li, Shi Qing-Wen, Gu Yu-Cheng and Kiyota Hiromasa, The Daphniphyllum Alkaloids, Current Organic Chemistry 2009; 13(6) . https://dx.doi.org/10.2174/138527209787847345
DOI https://dx.doi.org/10.2174/138527209787847345 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of YY1 in Oncogenesis and Its Potential as a Drug Target in Cancer Therapies
Current Cancer Drug Targets Cellular and Molecular Effects of Macrolides on Leukocyte Function
Current Pharmaceutical Design Nano-Neurotherapeutics (NNTs): An Emergent and Multifaceted Tool for CNS Disorders
Current Drug Metabolism A Review on Onychine and its Analogs: Synthesis and Biological Activity
Current Organic Synthesis An Update on Herbal Anti-inflammatory Agents in Periodontal Therapy
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) AAVs Anatomy: Roadmap for Optimizing Vectors for Translational Success
Current Gene Therapy Peroxisome Proliferator-Activated Receptors and their Ligands in Cancer Drug- Resistance: Opportunity or Challenge
Anti-Cancer Agents in Medicinal Chemistry Anti-cancer Effects of Curcumin on Head and Neck Cancers
Anti-Cancer Agents in Medicinal Chemistry Mesenchymal Cells in the Treatment of Spinal Cord Injury: Current & Future Perspectives
Current Stem Cell Research & Therapy In Vitro and In Vivo Models for Analysis of Resistance to Anticancer Molecular Therapies
Current Medicinal Chemistry Preventive and Therapeutic Role of Muscle Contraction Against Chronic Diseases
Current Pharmaceutical Design Nanoparticles Based on Plasma Proteins for Drug Delivery Applications
Current Pharmaceutical Design Chitin, Characteristic, Sources, and Biomedical Application
Current Pharmaceutical Biotechnology Blockade of Insulin-Like Growth Factor Type-1 Receptor with Cixutumumab (IMC-A12): A Novel Approach to Treatment for Multiple Cancers
Current Drug Targets Therapeutic Potential of microRNA Against Th2-associated Immune Disorders
Current Topics in Medicinal Chemistry Targeting Mitochondria in Fighting Cancer
Current Pharmaceutical Design Genomics and Proteomics of Nucleoside Transporters
Current Pharmacogenomics Bisphosphonates in the Prevention of Disease Recurrence: Current Results and Ongoing Trials
Current Cancer Drug Targets Proteinases as Biomarkers in Breast Cancer Prognosis and Diagnosis
Mini-Reviews in Medicinal Chemistry Receptor Mediated Tumor Targeting: An Emerging Approach for Cancer Therapy
Current Drug Delivery